Roche And C4 Expand Alliance Into Degrader-Antibody Conjugate Work

 
• By Joseph Haas
  
Medicine Researchers In A Laboratory
Roche and C4 expand their collaboration into DAC therapies for cancer (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business